Why Is GE HealthCare (GEHC) Up 3.6% Since Last Earnings Report?
GE HealthCare (GEHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
Why Abbott (ABT) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
Abbott (ABT) Stock Sinks As Market Gains: Here's Why
Abbott (ABT) concluded the recent trading session at $111.59, signifying a -2.2% move from its prior day's close.
Zacks
Abbott's next-generation Amulet 360 device receives CE Mark to treat people with atrial fibrillation at risk of stroke
Abbott's next-generation Amulet 360 device receives CE Mark to treat people with atrial fibrillation at risk of stroke Abbott's next-generation Amulet 360 device receives CE Mark to treat people with atrial fibrillation at risk of stroke PR Newswire ABBOTT PARK, Ill., Aug. 27, 2026 Amulet 360 helps...
PR Newswire
Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes
Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes PR Newswire ABBOTT PARK, Ill., Aug. 25, 2026 Libre Duo 10 Day is a...
PR Newswire
Abbott vs. DexCom: Which CGM Stock Is the Better Buy Now?
ABT edges DXCM on price-target upside and valuation, while both pursue CGM growth through innovation, adoption and strong liquidity.
Zacks
NVST or ABT: Which Is the Better Value Stock Right Now?
NVST vs. ABT: Which Stock Is the Better Value Option?
Zacks
Here's What Is Shaping Abbott's Diagnostics Growth
ABT's Diagnostics growth is being reshaped as weaker respiratory testing offsets healthy routine demand and 13% cancer diagnostics growth.
Zacks
Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?
Key PointsAbbott Laboratories has faced challenges, but it should successfully overcome them...
Nasdaq News: Markets
Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants
Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants PR Newswire ABBOTT PARK, Ill., Aug. 20, 2026 Agreements will resolve...
PR Newswire